BLACKBURN RELEASES CLINTON FOUNDATION REPORT
The “India success story” details the Clinton Foundation’s partnership with drug companies Ranbaxy, Matrix and Cipla in the subcontinent beginning in October 23, 2003. The Foundation joined the drug companies with the goal of combating HIV/AIDS in sub-Saharan Africa by getting less expensive medications into afflicted countries. This relationship saw the companies mature quickly and become acquisition targets for larger global pharmaceutical entities. It also resulted in encouragement for the disregard of intellectual property standards, the likely use of taxpayer money, through PEPFAR, to distribute watered down drugs that “subjected patients to increased risks of morbidity and mortality” , donations to the Foundation, and possible kickbacks in the form of million dollar consulting contracts to President Clinton from the friend of convicted felon and Ranbaxy advocate, Rajat Gupta.
· The Clinton Foundation Likely Facilitated The Distribution of Watered Down HIV/AIDS Medications In sub-Saharan Africa Through Its Health Access Initiative
· The Distribution of Watered Down HIV/AIDS Medications In sub-Saharan Africa May Have Increased Patient Mortality Rates
·Watered Down HIV/AIDS ARVs Were Purchased With Taxpayer Money Through PEPFAR As A Result of Price Agreements, Some of Which Were Likely Negotiated By The Clinton Foundation
·President Clinton Was Personally Enriched With Million Dollar Consulting Contracts By A Friend of Convicted Felon, and Ranbaxy advocate, Rajat Gupta From 2002-2008